Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference

NEW BRUNSWICK, N.J., Sept. 5, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley Global Health Care Conference Monday, September 10th, at the Grand Hyatt New York, 109 East 42nd Street at Grand Central, New York, NY.  Gary Pruden, Worldwide Chairman, Global Surgery Group for Johnson & Johnson will represent the company in a session scheduled at 1:15 p.m. (Eastern Time).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available shortly after the live webcast.

SOURCE Johnson & Johnson

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.